John­son & John­son or­dered to pay $55 mln in talc-pow­der trial

Enterprise - - International news -

John­son John­son was or­dered by a US jury to pay $55 mil­lion to a woman who said that us­ing the com­pany´s talc-pow­der prod­ucts for fem­i­nine hy­giene caused her to de­velop ovar­ian can­cer.

The ver­dict is the sec­ond straight trial loss for the com­pany, which is fac­ing ap­prox­i­mately 1,200 law­suits ac­cus­ing it of not ad­e­quately warn­ing con­sumers about its talc-based prod­ucts´ can­cer risks.

Fol­low­ing a three-week trial in Mis­souri state court, ju­rors de­lib­er­ated for about a day be­fore re­turn­ing a ver­dict in favour of plain­tiff Glo­ria Ris­te­sund.

J J spokesper­son Carol Goodrich said the ver­dict con­tra­dicted 30 years of re­search sup­port­ing the safety of cos­metic talc. The com­pany in­tends to ap­peal the jury´s de­ci­sion and will con­tinue de­fend­ing its prod­ucts´ safety, she said.

Ris­te­sund said she used J J´s talc-based pow­der prod­ucts which in­clude the well known Baby Pow­der and Shower-to-Shower Pow­der on her gen­i­tals for decades. Ac­cord­ing to her lawyers, she was di­ag­nosed with ovar­ian can­cer and had to un­dergo a hys­terec­tomy and re­lated surg­eries.

The ver­dict fol­lows a $72 mil­lion jury award from the same court in Fe­bru­ary 2016 to the fam­ily of a woman who died from ovar­ian can­cer af­ter years of us­ing talc pow­der for fem­i­nine hy­giene.

Plain­tiffs in talc lit­i­ga­tion, which is con­cen­trated in Mis­souri and New Jersey state courts, have ac­cused J J of fail­ing for years to warn that talc was linked to an in­creased risk for ovar­ian can­cer.

J J has said that it acted prop­erly in de­vel­op­ing and mar­ket­ing the prod­ucts.

Newspapers in English

Newspapers from Pakistan

© PressReader. All rights reserved.